Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

How mobile technology can improve clinical trials

David Lee Scher, MD
Tech
April 30, 2015
188 Shares
Share
Tweet
Share

I recently discussed both the merits and needs for the use of mobile technologies in clinical trials. Recruiting patients via social media is now a reality and has been a topic of discussion in many forums, including mainstream medical journals.  There is no question that online patient support groups serve unique purposes. There are regulatory issues involved in this arena.

However, new regulatory frameworks need to be developed in the age of digital and mobile trials with considerations to technology and patient populations. To be more specific, mobile technologies have unique issues to address. Crowdsourced clinical studies have been recognized as an emerging aspect of clinical research for years. Even funding for medical research has found its way to the masses.  Regardless of changes in the paradigm of conducting trials, patient safety must always remain a priority of study designers and investigators (whether organizational or subject investigators). The subject of health literacy is extremely important today. It is recognized as a major determinant of patient engagement. Health literacy is a critical factor in pharmaceutical and device labeling and is paramount to user experience of a mobile health app of any kind.

Improving patient recruiting, retention, and data collection should be the priorities of any mobile technology in this space. I am going to discuss why we can and need to adopt mobile technologies for clinical trials now.

1. Corporate giants are paving the way. Apple’s ResearchKit is a pioneering effort to accomplish many objectives. Its present offerings will not cure heart cancer (though arguably, if optimally utilized in association with other tools by both providers and patients it might prevent them). What it will do is to markedly increase awareness and enthusiasm of the public as well as the health care provider community to participate in clinical trials. ResearchKit’s present apps are primarily geared for wellness, with monitoring via smartphone sensors initially, but the satisfaction of participating in research and the sense of empowerment that participants will experience will pay huge dividends with regards to more disease-oriented research down the line. In addition, and not to be minimized, it will facilitate the adoption of mobile technology in general in the wellness and health care arenas.

2. The technology is here. One might intuitively think that a clinical trial mobile app might simply consist of a technology limited to data and symptom entry. But the dynamics and workflows of all phases of a clinical trial make that a recipe for poor recruiting and lack of patient engagement and thus retention. Parallel 6 is a company which utilizes patented technology in its end to end mobile clinical trial technology for improving both the recruiting and retention of study subjects. In addition, pharmaceutical companies are realizing the power of crowdsourced studies.  This is illustrated by the partnership deal between Genentech and 23andme.  These kinds of partnerships themselves spawn proliferation of mobile clinical trials.

3. Traditional evidence-based medicine is no longer considered infallible. As I have previously reported, there are significant cracks in the foundation of evidence-based clinical trials.  Some of these cracks may be due to well-publicized gender bias possibly related to recruitment practices (see below). These biases have been recognized by the FDA and stressed as a priority of attention in the recruiting of study subjects.  Social media as a source of study subject recruitment has multiple appealing aspects. It can facilitate recruitment of patients with rare diseases who reside in widely dispersed geographical regions. One study found that patients who are actively engaged in the use of social media for health care information are 60 percent more likely to have participated in a clinical trial compared to the general population. Clinical trial recruitment via social media can potentially decrease gender bias, leveling the clinical trial subject playing field. Amy Ohm, the CEO of Treatment Diaries, a large and successful online cross-disciplinary collection of support groups states that 73 percent of the site’s participants are female.

4. Traditional clinical trial research is becoming financially unfeasible. The cost of clinical trials is discouraging both sponsors and health care enterprises from conducting traditional clinical trials. The cost of even a market approved medical device trial for a new indication is tens of millions of dollars. The cost of clinical research nurses and coordinators has become prohibitive for institutions except those most famous or endowed. Although most research today is sponsor-driven, research by physicians in smaller hospitals and organizations is cost-prohibitive. Mobile technology can potentially assist in this regard. Even clinical research organizations (CROs) are looking to decrease costs and improve efficiency. The cost reduction projected for each phase of a trial in multiple disease state areas with the use of mobile technologies has been estimated in a recent report by the Department of Health and Human Services. “In Phase 1, the highest savings are $0.4 million (immunomodulation and respiratory system). The savings range from $0.5 million (cardiovascular) to $2.4 million (hematology) studies in Phase 2. In Phase 3, the highest savings that can be expected from the adoption of mobile technologies is $6.1 million (pain and anesthesia). Finally, the range of savings in Phase 4 studies is $0.7 million (genitourinary system) and $6.7 million (respiratory system).”

5. Mobile can improve trial safety and efficiencies in clinical workflow. With the collection of more data in real-time, the improved efficiencies produced with mobile technology might theoretically improve patient satisfaction, study subject retention, and the aforementioned cost to study sponsor and investigators.  In addition, earlier reporting of adverse events might translate to safer patient outcomes.  I truly look forward to pharmaceutical and medical device companies, CROs, payers, and health care institutions saving money which can be better utilized with the use of mobile technologies for clinical trials.

David Lee Scher is a cardiac electrophysiologist and a consultant, DLS Healthcare Consulting, LLC. He blogs at his self-titled site, David Lee Scher, MD.

Prev

The low-hanging fruit of health care costs

April 30, 2015 Kevin 5
…
Next

As an under-represented medical professional: Lean in

April 30, 2015 Kevin 1
…

Tagged as: Mobile health

Post navigation

< Previous Post
The low-hanging fruit of health care costs
Next Post >
As an under-represented medical professional: Lean in

More by David Lee Scher, MD

  • Want a successful digital health initiative? These 5 things need to happen first.

    David Lee Scher, MD
  • a desk with keyboard and ipad with the kevinmd logo

    Pharma needs physician digital key opinion leaders. Here’s why.

    David Lee Scher, MD
  • a desk with keyboard and ipad with the kevinmd logo

    5 reasons why physician champions are needed

    David Lee Scher, MD

More in Tech

  • Is AI the solution for the shortage of nephrologists? ChatGPT weighs in.

    Amol Shrikhande, MD
  • How AI is enhancing patient care and improving radiologists’ lives

    Brett Mollard, MD
  • ChatGPT masters USMLE: a real win for AI, but a long way from the art of medicine

    Harvey Castro, MD, MBA
  • The game-changing impact of AI regulation: Unlocking the potential in health care and society

    Harvey Castro, MD, MBA
  • Surviving TMI and AI: the importance of self-initiated self-learning for future physicians

    Deepak Gupta, MD and Sarwan Kumar, MD
  • Navigating the ethics of AI in surgery: Balancing bias and accountability for safer procedures

    Jag Singh, MD
  • Most Popular

  • Past Week

    • A patient’s perspective on the diminishing relationship between doctors and patients

      Michele Luckenbaugh | Conditions
    • Unmasking wage disparity in health care: the truth behind the Elmhurst Hospital physician strike

      Kevin Pho, MD | KevinMD
    • Why affirmative action is crucial for health equity and social justice in medicine

      Katrina Gipson, MD, MPH | Policy
    • How electronic health records preserve patients’ legacies in the words of oncologists

      Marc Braunstein, MD, PhD | Physician
    • Unmasking the brutal reality of gun violence in America: a call to action for unity and meaningful change

      Osmund Agbo, MD | Policy
    • Emulating Michael Jordan’s winning mindset: a path to success for health care professionals and entrepreneurs

      Harvey Castro, MD, MBA | Physician
  • Past 6 Months

    • The growing threat to transgender health care: implications for patients, providers, and trainees

      Carson Hartlage | Policy
    • Breaking point: the 5 reasons American doctors are dreaming of walking away from medicine

      Amol Shrikhande, MD | Physician
    • “Is your surgeon really skilled? The hidden threat to public safety in medicine.

      Gene Uzawa Dorio, MD | Physician
    • It’s time to replace the 0 to 10 pain intensity scale with a better measure

      Mark Sullivan, MD and Jane Ballantyne, MD | Conditions
    • Breaking the cycle of racism in health care: a call for anti-racist action

      Tomi Mitchell, MD | Policy
    • Revolutionize your practice: the value-based care model that reduces physician burnout

      Chandravadan Patel, MD | Physician
  • Recent Posts

    • The power of coaching for physicians: transforming thoughts, changing lives

      Kim Downey, PT | Conditions
    • Why doctors aren’t to blame for the U.S. opioid crisis [PODCAST]

      The Podcast by KevinMD | Podcast
    • Raw humanity on night float: inspiring patient encounters and overcoming challenges

      Johnathan Yao, MD, MPH | Physician
    • Is AI the solution for the shortage of nephrologists? ChatGPT weighs in.

      Amol Shrikhande, MD | Tech
    • Unlocking the secrets of cancer conferences: an end-of-life counselor’s journey among pharmaceutical giants

      Althea Halchuck, EJD | Conditions
    • Why HIPAA is failing and what you need to know to protect your data [PODCAST]

      The Podcast by KevinMD | Podcast

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

Leave a Comment

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

CME Spotlights

From MedPage Today

Latest News

  • What Drug Did FDA Just Approve for COVID?
  • PET Scan for Alzheimer's Dx; Predicting Colon Cancer Survival
  • What Happens When We Classify Kids' Weight as a 'Disease'?
  • Sotagliflozin Gets FDA's Blessing for Heart Failure
  • Cardiorespiratory Monitoring Can Be Telling of Outcomes in Extremely Preterm Infants

Meeting Coverage

  • No Access to Routine Healthcare Biggest Barrier to HPV Vaccination
  • Trial Results Spark Talk of Curing More Metastatic Cervical Cancers
  • Cross-Border Collaboration Improves Survival in Pediatric Leukemia Patients
  • Monoclonal Antibody Reduced Need For Transfusions in Low-Risk MDS
  • Less-Invasive Surgery for Pancreatic Cancer Proves Safe, Effective
  • Most Popular

  • Past Week

    • A patient’s perspective on the diminishing relationship between doctors and patients

      Michele Luckenbaugh | Conditions
    • Unmasking wage disparity in health care: the truth behind the Elmhurst Hospital physician strike

      Kevin Pho, MD | KevinMD
    • Why affirmative action is crucial for health equity and social justice in medicine

      Katrina Gipson, MD, MPH | Policy
    • How electronic health records preserve patients’ legacies in the words of oncologists

      Marc Braunstein, MD, PhD | Physician
    • Unmasking the brutal reality of gun violence in America: a call to action for unity and meaningful change

      Osmund Agbo, MD | Policy
    • Emulating Michael Jordan’s winning mindset: a path to success for health care professionals and entrepreneurs

      Harvey Castro, MD, MBA | Physician
  • Past 6 Months

    • The growing threat to transgender health care: implications for patients, providers, and trainees

      Carson Hartlage | Policy
    • Breaking point: the 5 reasons American doctors are dreaming of walking away from medicine

      Amol Shrikhande, MD | Physician
    • “Is your surgeon really skilled? The hidden threat to public safety in medicine.

      Gene Uzawa Dorio, MD | Physician
    • It’s time to replace the 0 to 10 pain intensity scale with a better measure

      Mark Sullivan, MD and Jane Ballantyne, MD | Conditions
    • Breaking the cycle of racism in health care: a call for anti-racist action

      Tomi Mitchell, MD | Policy
    • Revolutionize your practice: the value-based care model that reduces physician burnout

      Chandravadan Patel, MD | Physician
  • Recent Posts

    • The power of coaching for physicians: transforming thoughts, changing lives

      Kim Downey, PT | Conditions
    • Why doctors aren’t to blame for the U.S. opioid crisis [PODCAST]

      The Podcast by KevinMD | Podcast
    • Raw humanity on night float: inspiring patient encounters and overcoming challenges

      Johnathan Yao, MD, MPH | Physician
    • Is AI the solution for the shortage of nephrologists? ChatGPT weighs in.

      Amol Shrikhande, MD | Tech
    • Unlocking the secrets of cancer conferences: an end-of-life counselor’s journey among pharmaceutical giants

      Althea Halchuck, EJD | Conditions
    • Why HIPAA is failing and what you need to know to protect your data [PODCAST]

      The Podcast by KevinMD | Podcast

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Leave a Comment

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...